Clinical Trial Update: Determining the Safety of L-serine in ALS [Phase 1, Phase 2]

View source ↗

Summary

This entry notes an ongoing Phase 1/2 trial evaluating the safety of L-serine in amyotrophic lateral sclerosis (ALS). The current status is unknown, and no stud…

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Amyotrophic Lateral Sclerosis

Drugs mentioned

• L-serine (L-serine)

Snippet

Sponsor: Phoenix Neurological Associates, LTD | Conditions: Amyotrophic Lateral Sclerosis (ALS) | Phase 1, Phase 2 | Status: UNKNOWN